Unité STOCAD

Unité STOCAD is a board-certified psychiatrist and one of the leading TMS specialists serving Paris, Île-de-France. At the forefront of neuromodulation, Unité STOCAD brings advanced TMS solutions to patients in Paris.

After earning their medical degree from Sorbonne Université, Unité STOCAD completed an extensive residency in psychiatry with specialized training in interventional psychiatry and neuromodulation techniques. Over the past years, they have dedicated their career to helping patients who have not found relief from traditional treatments.

Unité STOCAD joined the team at Hôpital Pitié-Salpêtrière - Service de Psychiatrie Adulte to bring cutting-edge TMS therapy to Paris County. Their practice philosophy centers on the belief that every patient deserves a personalized treatment plan, combining the latest neuroscience research with compassionate, individualized care.

What sets Unité STOCAD apart is their commitment to staying at the forefront of psychiatric innovation. They regularly attend national conferences on neuromodulation, participate in clinical research, and maintain active membership in the Clinical TMS Society. This dedication ensures that patients at Hôpital Pitié-Salpêtrière - Service de Psychiatrie Adulte receive treatment protocols based on the latest evidence and best practices.

Unité STOCAD's approach to psychiatry is rooted in the understanding that mental health conditions like depression, anxiety, and OCD are medical conditions with neurological underpinnings—not character flaws or signs of weakness. This perspective shapes every aspect of their practice, from the initial consultation through the final maintenance session.

For patients who have tried multiple medications without success, Unité STOCAD offers TMS as a powerful alternative. Unlike oral medications that affect the entire body and often come with significant side effects, TMS delivers precisely targeted magnetic pulses to the specific brain regions responsible for mood regulation. This means patients can experience relief without the weight gain, sexual dysfunction, or cognitive fog commonly associated with antidepressants.

Unité STOCAD takes time to understand each patient's complete medical history, previous treatment attempts, and personal goals before recommending TMS. They believe that informed patients are empowered patients, so they thoroughly explain the science behind TMS, what to expect during treatment, and realistic outcomes.

Unité STOCAD's practice at Hôpital Pitié-Salpêtrière - Service de Psychiatrie Adulte is renowned for treating a range of mental health conditions, with particular expertise in:

Each condition requires a nuanced approach. For depression, Unité STOCAD typically recommends the standard 36-session protocol targeting the left dorsolateral prefrontal cortex. For OCD, they may use the BrainsWay Deep TMS system with its specialized H7 coil, which has specific FDA clearance for this condition.

Beyond these primary specialties, Unité STOCAD has experience treating bipolar depression, chronic pain, and smoking cessation through TMS. They work closely with each patient's existing healthcare team to ensure coordinated, comprehensive care.